Have multiple conditions? Click here

New Clinical Trials for High Blood Pressure (Hypertension)

High blood pressure clinical studies of sorts date back to the 6th century B.C. Some have even argued that there is evidence of it being documented going back to the 2nd century! Unfortunately, all of those studies have not yet resulted in a definitive way to diagnose, treat and ultimately cure high blood pressure. It is an often overlooked and underestimated disease.
 
If you are one of the millions of Americans who suffers from high blood pressure, please review the list of current high blood pressure clinical trials. Your participation could help us make the next big discovery in treating high blood pressure. Participation in clinical studies is always at no cost to you.
 

What is High Blood Pressure?

High Blood Pressure, or Hypertension, is a condition of chronic high blood pressure. There are two main types of hypertension – primary and secondary. Primary hypertension accounts for approximately 90 – 95% of the cases and no cause can be found for these cases. Secondary hypertension is the other 5 – 10% of the cases. These are diagnosed as being caused by other ailments. It is estimated that about 30% of the adult population in the United States suffers from high blood pressure, although not everyone manages it as a disease. Left untreated it can lead to a risk of stroke, heart failure, aneurysms, or kidney failure.
 

High Blood Pressure Treatments

Preventative treatments for high blood pressure include major lifestyle changes. Weight loss, exercise and diets lower in salt and sugar have been shown to be beneficial. The aim of drugs in treating high blood pressure is to reduce the blood pressure to a more normal state. This is often done with a combination of drugs that can include ACE inhibitors, alpha blockers and beta blockers.

Have multiple conditions? Click here

Showing 1-100 of 1114
There are 1114 High Blood Pressure (Hypertension) Clinical Trials
Name City State Zip
High Blood Pressure (Hypertension) Clinical Trial Birmingham AL 35216
High Blood Pressure (Hypertension) Clinical Trial Port Orange FL 32129
High Blood Pressure (Hypertension) Clinical Trial DeLand FL 32720
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB) Ozark AL 36360
Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure Montgomery AL 36106
Secondary Prevention of Small Subcortical Strokes Trial Mobile AL 36617
Study of Cicletanine for Pulmonary Arterial Hypertension (PAH) Mobile AL 36688
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication Mobile AL 36608
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB) Haleyville AL 35565
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH) Birmingham AL 35233
Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in PAH Subjects Birmingham AL 35294
A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) Birmingham AL
A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. Birmingham AL
A 16-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension (FREEDOM-C2) Birmingham AL 35233
Long-Term Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Hypertension and Kidney Disease. Birmingham AL
Calorie Restriction and Changes in Body Composition, Disease, Function, and Quality of Life in Older Adults Birmingham AL 35233
Idiopathic Intracranial Hypertension Treatment Trial Birmingham AL 35294
Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR) Birmingham AL 35294
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH) Birmingham AL 35233
Extension to QTI571A2301 to Evaluate the Long-term Safety, Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension Birmingham AL 35294
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB) Birmingham AL 35215
ACT-293987 in Pulmonary Arterial Hypertension Tuscon AZ 85704
Secondary Prevention of Small Subcortical Strokes Trial Tucson AZ 85724
Efficacy and Safety Study to Evaluate Combination Therapy With Nebivolol and Lisinopril vs. Placebo and Monotherapy in Patients With Stage 2 Diastolic Hypertension Tucson AZ 85741
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB) Tempe AZ 85282
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB) Tempe AZ 85282
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication Tempe AZ 85282
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication Tempe AZ 85282
Efficacy and Safety Study to Evaluate Combination Therapy With Nebivolol and Lisinopril vs. Placebo and Monotherapy in Patients With Stage 2 Diastolic Hypertension Tempe AZ 85282
Secondary Prevention of Small Subcortical Strokes Trial Scottsdale AZ 85259
Secondary Prevention of Small Subcortical Strokes Trial Phoenix AZ 85013
Labetalol Versus Magnesium Sulfate (MgSO4) for the Prevention of Eclampsia Trial Phoenix AZ 85013
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH) Phoenix AZ 85012
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH) Phoenix AZ 85054
Study of Cicletanine for Pulmonary Arterial Hypertension (PAH) Phoenix AZ 85013
A 16-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension (FREEDOM-C2) Phoenix AZ 85012
Study of Incidence of Respiratory Tract Adverse Events in Patients Treated With Tyvaso® Compared to Other FDA Approved Pulmonary Arterial Hypertension (PAH) Therapies Phoenix AZ 85013
ACT-293987 in Pulmonary Arterial Hypertension Phoenix AZ 85013
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB) Phoenix AZ 85013
A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) Peoria AZ
Long-Term Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Hypertension and Kidney Disease. Peoria AZ
A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH) Glendale AZ 85304
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB) Gilbert AZ 85234
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication Gilbert AZ 85234
Ambulatory Blood Pressure Monitoring in Children Little Rock AR 72202
Azilsartan Medoxomil Study in Hypertensive Children Little Rock AR
Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular Hypertension Little Rock AR
Efficacy and Safety Study to Evaluate Combination Therapy With Nebivolol and Lisinopril vs. Placebo and Monotherapy in Patients With Stage 2 Diastolic Hypertension Jonesboro AR 72401
Study of Safety and Efficacy Of PF-04971729 In Patients With Type 2 Diabetes And Hypertension Fayetteville AR 72703
The Autonomic Nervous System and Obesity Ventura CA 93003
Treatment of Supine Hypertension in Autonomic Failure Ventura CA 93003
The Effect of a Peroxisome Proliferator-activated Receptor (PPAR) Alpha Agonist on Cytochrome P450 (CYP) Monooxygenase Activity in Humans Ventura CA 93003
Contribution of Angiotensin II to Supine Hypertension in Autonomic Failure Ventura CA 93003
Nebivolol in the Supine Hypertension of Autonomic Failure Ventura CA 93003
The Role of Endothelin in the Supine Hypertension of Autonomic Failure Ventura CA 93003
Pathophysiology of Cardiometabolic Risk Factors in African Americans Ventura CA 93003
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB) Tustin CA
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication Tustin CA
Efficacy and Safety Study to Evaluate Combination Therapy With Nebivolol and Lisinopril vs. Placebo and Monotherapy in Patients With Stage 2 Diastolic Hypertension Tustin CA 92780
Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH) Torrance CA 90509
A 16-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension (FREEDOM-C2) Torrance CA 90509
Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medication Torrance CA 90509
Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH) Torrance CA 90509
Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients Torrance CA 90509
Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR) Torrance CA 90502
ACT-293987 in Pulmonary Arterial Hypertension Torrance CA 90502
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients Stanford CA 94305
Insulin Resistance in Pulmonary Arterial Hypertension Stanford CA 94305
A 48-week Study of the Effect of Dual Therapy (Inhaled Treprostinil and Tadafafil) Versus Mono-therapy (Tadalafil), 2 FDA Approved Pulmonary Hypertension Medications Stanford CA 94305
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH) Stanford CA 94305
A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) Santa Clara CA 95051
A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. Santa Clara CA 95051
Long-Term Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Hypertension and Kidney Disease. Santa Clara CA 95051
A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction Santa Clara CA 95051
Safety and Efficacy of Different Formulations of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension Santa Clara CA 95051
Safety and Efficacy of AGN-210961 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension Santa Clara CA 95051
Safety and Pharmacodynamics Study of AGN-207281 Ophthalmic Solutions Compared With Timolol Ophthalmic Solution or Placebo in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma Santa Clara CA 95051
Ventavis® Registry Protocol Santa Barbara CA 93105
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication Santa Ana CA 92701
Efficacy and Safety Study to Evaluate Combination Therapy With Nebivolol and Lisinopril vs. Placebo and Monotherapy in Patients With Stage 2 Diastolic Hypertension Santa Ana CA 92705
Efficacy and Safety Study to Evaluate Combination Therapy With Nebivolol and Lisinopril vs. Placebo and Monotherapy in Patients With Stage 2 Diastolic Hypertension San Ramon CA 94583
Efficacy and Safety Study to Evaluate Combination Therapy With Nebivolol and Lisinopril vs. Placebo and Monotherapy in Patients With Stage 2 Diastolic Hypertension San Marino CA 91108
Evaluation of Pascal Laser Trabeculoplaty San Jose CA 95128
Secondary Prevention of Small Subcortical Strokes Trial San Francisco CA 94143
Chronic Sildenafil for Severe Diaphragmatic Hernia San Francisco CA 94115
Effect of Exercise and Diet on Inflammation in Hypertensive Individuals San Francisco CA 94110
Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH) San Francisco CA 94143
The Efficacy of Selective Laser Trabeculoplasty San Francisco CA 94105
Evaluating the Relationship Between Stress, Ethnicity, and Blood Pressure San Francisco CA 94110
Epidemiology and Pathogenesis of HIV-Associated Pulmonary Hypertension San Francisco CA 94115
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities San Francisco CA 94143
Treating to Target for Patients With Hypertension San Francisco CA 94110
Multilevel Intervention for Physical Activity in Retirement Communities San Francisco CA 94110
Effects of the Beta-blocker Nebivolol (Bystolic) on Subjects With High Normal Blood Pressure and/or a Family History of Hypertension San Francisco CA 94110
Study of Medical Assistant Health Coaching in Primary Care for Patients With Chronic Conditions San Francisco CA 94110
A New Translational Tool for Studying the Role of Breathing in Meditation San Francisco CA 94143
Secondary Prevention of Small Subcortical Strokes Trial San Diego CA 92103
Effect of Low Socionomic Status and Psychosocial Factors on Cardiovascular Disease Risk in Mexican-American Women San Diego CA 92123
Study of Cicletanine for Pulmonary Arterial Hypertension (PAH) San Diego CA 92103
Epoprostenol for Injection in Pulmonary Arterial Hypertension San Diego CA 92103

Showing 1-100 of 1114
Alabama - Alaska - Arizona - Arkansas - California - Colorado - Connecticut - Delaware - Washington DC - Florida - Georgia - Hawaii - Idaho - Illinois - Indiana - Iowa - Kansas - Kentucky - Louisiana - Maine - Maryland - Massachusetts - Michigan - Minnesota - Mississippi - Missouri - Montana - Nebraska - Nevada - New Hampshire - New Jersey - New Mexico - New York - North Carolina - North Dakota - Ohio - Oklahoma - Oregon - Pennsylvania - Rhode Island - South Carolina - South Dakota - Tennessee - Texas - Utah - Vermont - Virginia - Washington - West Virginia - Wisconsin - Wyoming
For Sponsors: Promote Your Study | For Research Sites: Promote Your Site

Copyright 2012 Clinical Trials Institute, LLC | All Rights Reserved
Login
Forgot password?
Enter your email and we will resend your password
Register